Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCarron, S. L.
Right arrow Articles by Howell, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCarron, S. L.
Right arrow Articles by Howell, W. M.
[Cancer Research 62, 3369-3372, June 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Influence of Cytokine Gene Polymorphisms on the Development of Prostate Cancer1

Sarah L. McCarron, Stephen Edwards, Philip R. Evans, Roz Gibbs, David P. Dearnaley, Anna Dowe, Christine Southgate The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators2, Douglas F. Easton, Rosalind A. Eeles and W. Martin Howell3

Department of Histocompatibility and Immunogenetics, Southampton University Hospitals NHS Trust, Southampton SO16 6YD [S. L. M., P. R. E., W. M. H.]; Institute of Cancer Research, Royal Marsden Hospital NHS Trust, Sutton, Surrey SM2 5PT [S. E., D. P. D., A. D., C. S., R. A. E.]; University of Portsmouth, Portsmouth PO1 2RY [R. G.]; and CRC Genetic Epidemiology Unit, Strangeways Laboratories, Cambridge CB1 4RN [D. F. E.], United Kingdom

Polymorphisms in the promoter regions of cytokine genes may influence prostate cancer (PC) development via regulation of the antitumor immune response and/or pathways of tumor angiogenesis. PC patients (247) and 263 controls were genotyped for interleukin (IL)-1ß-511, IL-8-251, IL-10-1082, tumor necrosis factor-{alpha}-308, and vascular endothelial growth factor (VEGF)-1154 single nucleotide polymorphisms. Patient control comparisons revealed that IL-8 TT and VEGF AA genotypes were decreased in patients compared with controls [23.9 versus 32.3%; P = 0.04, odds ratio (OR) = 0.66, 95% confidence interval (CI) 0.44–0.99 and 6.3 versus 12.9%; P = 0.01, OR = 0.45, 95% CI 0.24–0.86, respectively], whereas the IL-10 AA genotype was significantly increased in patients compared with controls (31.6 versus 20.6%; P = 0.01, OR = 1.78, 95% CI 1.14–2.77). Stratification according to prognostic indicators showed association between IL-8 genotype and log prostate-specific antigen level (P = 0.05). These results suggest that single nucleotide polymorphisms associated with differential production of IL-8, IL-10, and VEGF are risk factors for PC, possibly acting via their influence on angiogenesis.




This article has been cited by other articles:


Home page
 Ann OncolHome page
G. Lurje, W. Zhang, A. M. Schultheis, D. Yang, S. Groshen, A. E. Hendifar, H. Husain, M. A. Gordon, F. Nagashima, H. M. Chang, et al.
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
Ann. Onc., June 11, 2008; (2008) mdn368v1.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Seaton, P. Scullin, P. J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher, J. M. O'Sullivan, P. G. Johnston, and D. J. J. Waugh
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
Carcinogenesis, June 1, 2008; 29(6): 1148 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. J. Jacobs, A. W. Hsing, E. B. Bain, V. L. Stevens, Y. Wang, J. Chen, S. J. Chanock, S. L. Zheng, J. Xu, M. J. Thun, et al.
Polymorphisms in Angiogenesis-Related Genes and Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 972 - 977.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Zabaleta, H.-Y. Lin, R. A. Sierra, M.C. Hall, P. E. Clark, O. A. Sartor, J. J. Hu, and A. C. Ochoa
Interactions of cytokine gene polymorphisms in prostate cancer risk
Carcinogenesis, March 1, 2008; 29(3): 573 - 578.
[Abstract] [Full Text] [PDF]

Home page
 Biol Res NursHome page
A. H. T. Davis, Jianhua Wang, T. C. Tsang, and D. T. Harris
Direct Sequencing Is More Accurate and Feasible in Detecting Single Nucleotide Polymorphisms than RFLP: Using Human Vascular Endothelial Growth Factor Gene as a Model
Biol Res Nurs, October 1, 2007; 9(2): 170 - 178.
[Abstract] [PDF]

Home page
 Mol Cancer ResHome page
C. F. MacManus, J. Pettigrew, A. Seaton, C. Wilson, P. J. Maxwell, S. Berlingeri, C. Purcell, M. McGurk, P. G. Johnston, and D. J.J. Waugh
Interleukin-8 Signaling Promotes Translational Regulation of Cyclin D in Androgen-Independent Prostate Cancer Cells
Mol. Cancer Res., July 1, 2007; 5(7): 737 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. A. Hefler, A. Mustea, D. Konsgen, N. Concin, B. Tanner, R. Strick, G. Heinze, C. Grimm, E. Schuster, C. Tempfer, et al.
Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer
Clin. Cancer Res., February 1, 2007; 13(3): 898 - 901.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
W. M. Howell and M. J. Rose-Zerilli
Cytokine Gene Polymorphisms, Cancer Susceptibility, and Prognosis
J. Nutr., January 1, 2007; 137(1): 194S - 199S.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Kataoka, Q. Cai, W. Wen, X.-O. Shu, F. Jin, Y.-T. Gao, and W. Zheng
Population-Based Case-Control Study of VEGF Gene Polymorphisms and Breast Cancer Risk among Chinese Women.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1148 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. S. Michaud, S. E. Daugherty, S. I. Berndt, E. A. Platz, M. Yeager, E. D. Crawford, A. Hsing, W.-Y. Huang, and R. B. Hayes
Genetic Polymorphisms of Interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and Risk of Prostate Cancer.
Cancer Res., April 15, 2006; 66(8): 4525 - 4530.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. A. Savage, L. Hou, J. Lissowska, W.-H. Chow, W. Zatonski, S. J. Chanock, and M. Yeager
Interleukin-8 polymorphisms are not associated with gastric cancer risk in a polish population.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 589 - 591.
[Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Taguchi, N. Ohmiya, K. Shirai, N. Mabuchi, A. Itoh, Y. Hirooka, Y. Niwa, and H. Goto
Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2487 - 2493.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. S. Seo, S.-S. Lee, S. I. Kim, W. H. Ryu, K. H. Sa, S. U. Kim, S. W. Han, E. J. Nam, J. Y. Park, W. K. Lee, et al.
Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis
Rheumatology, October 1, 2005; 44(10): 1299 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
W M Howell, P J Pead, F W Shek, M J Rose-Zerilli, T Armstrong, C D Johnson, D R Fine, J P Iredale, and A C Bateman
Influence of cytokine and ICAM-1 gene polymorphisms on susceptibility to chronic pancreatitis
J. Clin. Pathol., June 1, 2005; 58(6): 595 - 599.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Murphy, M. McGurk, J. Pettigrew, A. Santinelli, R. Mazzucchelli, P. G. Johnston, R. Montironi, and D. J.J. Waugh
Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer
Clin. Cancer Res., June 1, 2005; 11(11): 4117 - 4127.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, R. Klaes, R. Henriksson, B. Chen, J. Pamula, W. Pekala, et al.
Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis
Clin. Cancer Res., May 15, 2005; 11(10): 3647 - 3653.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. J. Lee, S. Y. Lee, H.-S. Jeon, S. H. Park, J. S. Jang, G. Y. Lee, J. W. Son, C. H. Kim, W. K. Lee, S. Kam, et al.
Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 571 - 575.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Lu, K. Pan, L. Zhang, D. Lin, X. Miao, and W. You
Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population
Carcinogenesis, March 1, 2005; 26(3): 631 - 636.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Fang, X. Jin, R. Wang, Y. Li, W. Guo, N. Wang, Y. Wang, D. Wen, L. Wei, and J. Zhang
Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China
Carcinogenesis, February 1, 2005; 26(2): 481 - 486.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C. CARUSO, D. LIO, L. CAVALLONE, and C. FRANCESCHI
Aging, Longevity, Inflammation, and Cancer
Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 1 - 13.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. W. Han, G. W. Kim, J. S. Seo, S. J. Kim, K. H. Sa, J. Y. Park, J. Lee, S. Y. Kim, J. J. Goronzy, C. M. Weyand, et al.
VEGF gene polymorphisms and susceptibility to rheumatoid arthritis
Rheumatology, September 1, 2004; 43(9): 1173 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
F. Lindmark, S. L. Zheng, F. Wiklund, J. Bensen, K. A. Balter, B. Chang, M. Hedelin, J. Clark, P. Stattin, D. A. Meyers, et al.
H6D Polymorphism in Macrophage-Inhibitory Cytokine-1 Gene Associated With Prostate Cancer
J Natl Cancer Inst, August 18, 2004; 96(16): 1248 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. S. ROGERS, R. M. ROHAN, A. E. BIRSNER, and R. J. D'AMATO
Genetic loci that control the angiogenic response to basic fibroblast growth factor
FASEB J, July 1, 2004; 18(10): 1050 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
K. Asadullah, W. Sterry, and H. D. Volk
Interleukin-10 Therapy--Review of a New Approach
Pharmacol. Rev., June 1, 2003; 55(2): 241 - 269.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.